This Mendelian randomization study reveals that elevated CCL19 increases tinnitus risk via pantothenate‐mediated inflammation, implicating the CCL19‐pantothenate‐TLR4/NF‐κB axis as a causal pathway. The gene discussed is TLR4; the disease is Tinnitus.